Centro Médico Teknon
Centro Médico Teknon
Hiszpania, Barcelona
Bartolome Oliver
50 lat doświadczenia • 280+ procedury na koncie
akredytacje :
Akredytacje :
Neuroblastoma treatment cost in Spain typically ranges from $70,000 to $130,000 for comprehensive therapeutic protocols. Initial costs often include a consultation with an oncologist, which runs from $200 to $400. Total expenses depend on the cancer stage, the necessity of CAR NK cell therapy, and the specific hospital tier. Patients generally see 33-50% savings compared to the United States. Leading treatment centers are located in Barcelona and Madrid.
Typical Neuroblastoma Treatment Costs in Spain
Bookimed Expert Insight: High-risk cases benefit most from multidisciplinary care at centers like SJD Barcelona Children's Hospital. As a top 3 European pediatric institution, they offer specialized molecular medicine led by experts like Dr. Jaume Mora Graupera. For patients seeking advanced technology, Quironsalud Madrid provides Spain's first dedicated proton therapy center. These JCI-accredited facilities offer clinical trials and integrated surgical oncology for complex tumors.
| Turcja | Austria | Hiszpania | |
| Kompleksowe leczenie neuroblastomy | od $28,000 | od $180,000 | od $70,000 |
Dr Graupera jest uznanym onkologiem dziecięcym, która kieruje Oddziałem Hematologii i Onkologii w SJD Barcelona Children's Hospital — jednym z najlepszych szpitali dziecięcych w Europie.
Ponad 20 lat specjalizuje się w hematologii i onkologii dziecięcej – dr Lopez Ibor kieruje Oddziałem Hematologii i Onkologii Dziecięcej w HM Montepríncipe.
Od ponad 30 lat specjalizuje się w onkologii dziecięcej — dr Lopez Ibor kieruje Oddziałem Hematologii i Onkologii Dziecięcej w HM Hospitales w Madrycie. Skupia się na leczeniu ciężkich nowotworów wieku dziecięcego.
Dr Bartolome Oliver praktykuje od 1979 r. i wykonuje zabiegi mikrochirurgiczne oraz wykorzystuje aparaty nieinwazyjnej radiochirurgii. Udziela konsultacji online i jest członkiem różnych międzynarodowych społeczności medycznych. Jest autorem 150 publikacji i 350 raportów na międzynarodowych konferencjach medycznych.
Spain is home to internationally recognized pediatric oncology centers specializing in high-risk neuroblastoma care. SJD Barcelona Childrens Hospital is a global leader. It reports a 91.6% 3-year survival rate for patients in first remission. Other key institutions include Vall dHebron and Hospital Universitario HM Madrid.
Bookimed Expert Insight: While many large hospitals treat pediatric cancers, true specialization in neuroblastoma is concentrated in Barcelona and Madrid. SJD Barcelona Childrens Hospital manages over 450,000 patients annually and belongs to the top three European centers for pediatric oncology. Dr. Jaume Mora at SJD is highly sought after for protocols that avoid high-dose chemotherapy. If you need advanced molecular diagnostics or CAR NK cell therapy, these specific Spanish hubs are your best choice due to their high volume of over 5,000 pediatric procedures yearly.
Patient Consensus: Patients note it is vital to choose centers in Madrid or Barcelona where neuroblastoma volume is highest. Families emphasize confirming if the hospital manages entire treatment cycles including surgery and stem-cell backup under one roof.
Spain hosts world-renowned pediatric oncologists specializing in high-risk neuroblastoma. Key leaders include Dr. Jaume Mora Graupera at SJD Barcelona and Dr. Blanca Lopez Ibor at HM Madrid. These specialists utilize advanced molecular testing and anti-GD2 immunotherapy within JCI-accredited facilities.
Bookimed Expert Insight: Spain is a global leader for neuroblastoma, ranking 2nd in our medical destination data. While most seek famous names, our data shows institutional capacity matters most. SJD Barcelona serves 450,000 yearly patients, providing the high-volume experience necessary for complex relapsed cases.
Patient Consensus: Parents recommend finding a multidisciplinary team rather than one physician. They suggest asking how many neuroblastoma cases the lead doctor handles annually to ensure proficiency in managing high-risk disease.
Spain provides full access to advanced anti-GD2 immunotherapies for high-risk neuroblastoma. European Medicines Agency (EMA) approved drugs like Dinutuximab Beta are standard care protocols. Specialized centers in Barcelona and Madrid also provide next-generation therapies like Naxitamab under strict regulatory frameworks.
Bookimed Expert Insight: SJD Barcelona Children's Hospital managed 450,000 patient visits annually and serves as a global leader. Their protocol for Naxitamab is uniquely designed for low-toxicity. This is vital because anti-GD2 infusions typically require intensive pain management. Choosing a center with these specific specialized nursing teams significantly improves your child's comfort during the process.
Patient Consensus: Parents emphasize that access to these therapies depends on being at a major tertiary center. They recommend asking if the hospital routinely manages high-risk cases with anti-GD2 before starting treatment.
International patients can access neuroblastoma clinical trials in Spain. The country is a leading European research hub. It participates in major consortia like the International Society of Paediatric Oncology. Centers often offer early-phase trials and targeted anti-GD2 immunotherapy for high-risk or relapsed cases.
Bookimed Expert Insight: While SJD Barcelona Children's Hospital is a global leader performing 14,000 operations annually, Quironsalud Madrid offers a unique advantage for international families. Their protocol explicitly allows eligible patients to participate in clinical trials for free. This is a vital differentiator as many centers only cover the study drug while charging for standard hospital stays and diagnostics.
Patient Consensus: Families emphasize that logistics are often harder than meeting medical eligibility. Success requires coordinating frequent imaging, lab monitoring, and long stays in Spain while managing language barriers and non-study medical costs.
To obtain a medical second opinion in Spain, submit comprehensive medical records including pathology and imaging to JCI-accredited clinics. International departments coordinate remote video consultations or documentary reviews. Specialist oncologists typically provide a written report validating diagnosis or treatment plans for complex conditions like neuroblastoma.
Bookimed Expert Insight: Spain ranks highly for complex pediatric oncology because top centers integrate specialized molecular medicine laboratories. SJD Barcelona Children's Hospital handles 450,000 patients annually and uses dedicated research labs to refine neuroblastoma staging. For the most accurate second opinion, choose clinics with multidisciplinary teams that include pediatric radiologists and molecular pathologists.
Patient Consensus: Patients note it is essential to provide high-quality medical translations to avoid delays. Many emphasize that having a written report is vital for coordinating care with their home oncology team.